4//SEC Filing
Sorrento Therapeutics, Inc. 4
Accession 0000899243-16-024984
CIK 0000850261operating
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 5:00 PM ET
Size
5.5 KB
Accession
0000899243-16-024984
Insider Transaction Report
Form 4
Deming David H
Director
Transactions
- Award
Stock Options
2016-07-11+35,000→ 105,000 totalExercise: $6.44Exp: 2026-07-11→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]1/12 of the original number of shares subject to this option shall vest and become exercisable following each one month of service thereafter, subject to the reporting person's continued service on the issuer's board of directors on each such date.
Documents
Issuer
Sorrento Therapeutics, Inc.
CIK 0000850261
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000850261
Filing Metadata
- Form type
- 4
- Filed
- Jul 11, 8:00 PM ET
- Accepted
- Jul 12, 5:00 PM ET
- Size
- 5.5 KB